Home » Topics » BioWorld Science

BioWorld Science
RSS

Actinogen reports cognition data on Xanamem in healthy elderly subjects

Oct. 3, 2019

Phase III THEMIS-PCI results on ticagrelor published

Oct. 3, 2019

XBiotech initiates phase II study of bermekimab in systemic sclerosis

Oct. 3, 2019

Shanghai Allist Pharmaceutical describes new PARP inhibitors

Oct. 3, 2019

New GABRA5 inverse agonists discovered at Shanghai SIMR Biotech

Oct. 3, 2019

Adynxx receives funding award to develop nonopioid chronic pain product candidate

Oct. 3, 2019

Biomica begins preclinical studies with microbial consortia BMC-321 and BMC-322 for IBD

Oct. 3, 2019

Discovery of novel small-molecule inhibitor of PWWP1 domain of NSD3 for acute myeloid leukemia

Oct. 3, 2019

IOCB Prague and Univerzita Palackeho v Olomouci disclose nucleoside derivatives

Oct. 3, 2019

US Department of Health & Human Services and collaborators describe D1 receptor PAMs

Oct. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...